Showing results (151-160 of 261) with videos related to
Sort By:
Pageof 27
Frontiers in Microbiology|September 2, 2025
Long-term neurocognitive outcomes of SARS-CoV-2 infection in a hamster modelCarla Ruiz-Casas, Ferran Tarrés-Freixas, Núria Roca, et al.Journal of Clinical Immunology|October 31, 2002
Cytotoxic HIV-1 p55gag-specific CD4+ T cells produce HIV-inhibitory cytokines and chemokinesBarbara Lotti, Thomas Wendland, Hansjakob Furrer, et al.Journal of Virology|January 16, 2015
Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1Christoph T Berger, Anuska Llano, Jonathan M Carlson, et al.The Journal of Infectious Diseases|October 28, 2024
Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral BloodLucía Bailón, Maria C Puertas, Maria C García-Guerrero, et al.AIDS Research and Human Retroviruses|September 10, 2013
HIV subtype influences HLA-B*07:02-associated HIV disease outcomeHenrik N Kløverpris, Emily Adland, Madoka Koyanagi, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern AfricaIsobella Honeyborne, Almas Rathod, Rico Buchli, et al.Journal of Virology|October 20, 2021
Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing ResponsesCarolina Beltran-Pavez, Ilja Bontjer, Nuria Gonzalez, et al.Journal of Virology|November 24, 2017
Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 InfectionEmily Adland, Matilda Hill, Nora Lavandier, et al.Journal of Virology|January 11, 2008
Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activityAviva Joseph, Jian Hua Zheng, Antonia Follenzi, et al.Frontiers in Microbiology|July 11, 2026
Persistent neurological and behavioral alterations after SARS-CoV-2 infection in an optimized K18-hACE2 mouse modelCarla Ruiz-Casas, Ferran Tarrés-Freixas, Núria Roca, et al.Pageof 27